Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Global Blood Therapeutics...

    NASDAQ: GBT · Real-Time Price · USD
    68.49
    0.01 (0.01%)
    At close: Oct 04, 2022, 10:00 PM

    Global Blood Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Revenue
    		 194.75M
    Cost of Revenue
    		 3.32M
    Gross Profit
    		 191.43M
    Operating Income
    		 -287.15M
    Interest Income
    		 720K
    Pretax Income
    		 -302.61M
    Net Income
    		 -303.09M
    Selling & General & Admin
    		 266.99M
    Research & Development
    		 212.13M
    Other Expenses
    		 n/a
    Operating Expenses
    		 479.12M
    Interest Expense
    		 15.47M
    Selling & Marketing Expenses
    		 n/a
    Cost & Expenses
    		 482.44M
    Income Tax Expense
    		 477K
    Shares Outstanding (Basic)
    		 62.93M
    Shares Outstanding (Diluted)
    		 62.93M
    EPS (Basic)
    		 -4.82
    EPS (Diluted)
    		 -4.82
    EBITDA
    		 -278.53M
    EBIT
    		 -286.6M
    Depreciation & Amortization
    		 8.62M

    Add to Watchlist